![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS NEW DEVELOPMENTS IN THE TREATMENT OF COMPLEX LOWER EXTREMITY LESIONS
The Journal of Cardiovascular Surgery 2015 February;56(1):73-9
Copyright © 2015 EDIZIONI MINERVA MEDICA
language: English
Treatment of the aorto-iliac segment in complex lower extremity arterial occlusive disease
Wressnegger A., Kinstner C., Funovics M. ✉
Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image‑Guided Therapy, Medical University of Vienna, Vienna, Austria
Endovascular treatment of the aortoiliac segment in occlusive disease has an established role especially in TASC A and B lesions. Recent studies with modern stent technology have shown excellent results with one-year primary patency above 95%. Regarding different endovascular approaches, there is level Ib evidence supporting provisional stenting in stenosed arteries, and primary stenting in occlusion. While open surgery shows higher patency rates in direct comparison to endovascular techniques, the latter show significantly lower complication rates and lower mortality. The recommendations reserving TASC C and D lesions exclusively to surgery are currently challenged, especially in poor surgical candidates.